Stock Report

Download full stock data and analysis for free Last Updated: 02-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

AC Immune SA - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$2.68

up-down-arrow $0.04 (1.52%)

As on 01-Sep-2026 16:02EDT

Market cap

info icon

$263 Mln

Revenue (TTM)

info icon

$18 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

6.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 1,250.58 1,057.20 -39.45 64.48 53.31
EBIT -- -- 40.04 15.62 9.74
Net Profit 112.66 108.84 14.56 10.58 7.25
EPS 112.66 109.02 13.75 13.31 9.52
Book Value -- -- -60.10 -39.66 -31.66
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -839.14-2,395.37-172.39-1,966.30-185.95
Net Margin info -----246.49----
Return on equity info -53.28-45.55-107.75-89.62-37.31
Return on Capital info -50.90-43.95---84.28-36.13
Return on Assets info -30.20-30.28-15.99-36.56-24.61
Debt to Equity (x) info ----0.000.100.05

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
-84.28
-36.13
-32.29
-34.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-107.75

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-107.75
-89.62
-37.31
-32.90
-35.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-15.99

Higher than Peers by 22.28

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-15.99
-36.56
-24.61
-29.41
-31.63
Peer Median
-38.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-172.39

Higher than Peers by 6.50

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-172.39
-1,966.30
-185.95
-365.16
-1,788.69
Peer Median
-178.89
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-246.49

Lower than Peers by 33.00

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-246.49
-1,971.65
-186.44
-366.41
-1,798.04
Peer Median
-213.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Lower than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-39.45

Lower than Peers by 41.29

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-39.45
-0.87
0.85
2.76
3.17
Peer Median
1.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

40.04

Higher than Peers by 15.69

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
40.04
-38.35
6.04
23.21
2.80
Peer Median
24.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

14.56

Lower than Peers by 19.30

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
14.56
-38.36
6.12
23.35
3.07
Peer Median
33.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

13.75

Lower than Peers by 26.04

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
13.75
-0.38
0.22
0.24
0.08
Peer Median
39.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-52.01

Lower than Peers by 49.66

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-52.01
--
--
--
--
Peer Median
-2.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
0.10
0.05
0.02
0.02
Peer Median
-0.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
0.02
0.02
0.01
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.93

Lower than Peers by 5.23

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
0.93
1.02
1.71
9.22
11.16
Peer Median
6.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.93

Lower than Peers by 4.97

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
0.93
--
--
9.26
11.16
Peer Median
5.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-200.97

Lower than Peers by 198.52

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
-200.97
-367.83
-381.80
-307.09
-198.27
Peer Median
-2.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

77.93

Higher than Peers by 49.25

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
77.93
37.45
4.02
101.66
10.37
Peer Median
28.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.06

Lower than Peers by 0.08

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
0.06
0.02
0.13
0.08
0.02
Peer Median
0.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
124.56
107.97
190.68
64.19
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
--
-3.63
-2.08
-4.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
--
12.66
8.72
8.87
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
AC Immune SA - ADR
--
--
91.68
179.88
51.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...